MORE►
Alessa Therapeutics
[Illustration: Vitanovski via iStock]
The Last Word: Celanese’s Karen Chen on Partnering with Alessa Therapeutics on Cancer Drug Delivery
by Dallas Innovates | Staff Report | Mar 1, 2023
Dallas-based Celanese Corporation has announced a collaboration with Alessa Therapeutics for developing a new oncology drug product, by utilizing the Celanese VitalDose EVA drug delivery platform. "Our new collaboration with Alessa Therapeutics underscores our commitment to optimize therapeutics through drug delivery innovation for oncology patients,” said Karen Chen, global business strategy leader for oncology at
Celanese.
